Nutra Pharma annual free cash flow
2010
2011
2012
2014
2015
2016
2017
2020
2021
2022
2025
Nutra Pharma Free Cash Flow (FCF) History (NPHC)
Nutra Pharma reported −$1.2M in free cash flow for fiscal 2025, a free cash flow margin of −461.94%.
View full Nutra Pharma company overviewNutra Pharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$1.2M | — | — | −461.94% |
| 2022 | 2022-12-31 | −$820,425 | $963,087 | — | −562.71% |
| 2021 | 2021-12-31 | −$1.8M | −$899,521 | — | −1824.84% |
| 2020 | 2020-12-31 | −$883,991 | — | — | −1703.36% |
| 2017 | 2017-12-31 | −$1.1M | $212,420 | — | −948.48% |
| 2016 | 2016-12-31 | −$1.4M | −$340,974 | — | −807.74% |
| 2015 | 2015-12-31 | −$1.0M | −$849,227 | — | −349.78% |
| 2014 | 2014-12-31 | −$169,679 | — | — | −28.54% |
| 2012 | 2012-12-31 | −$721,242 | $1.2M | — | −354.78% |
| 2011 | 2011-12-31 | −$1.9M | −$459,296 | — | −1183.89% |
| 2010 | 2010-12-31 | −$1.4M | — | — | −99.87% |
Nutra Pharma quarterly free cash flow
Q3.10
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q1.15
Q2.15
Q3.15
Q4.15
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −$219,818 | — | — | −761.56% |
| Q3 2025 | 2025-09-30 | −$250,770 | — | — | −357.01% |
| Q2 2025 | 2025-06-30 | −$288,370 | — | — | −341.14% |
| Q1 2025 | 2025-03-31 | −$431,058 | — | — | −582.72% |
| Q4 2022 | 2022-12-31 | −$54,032 | $183,923 | — | −68.41% |
| Q3 2022 | 2022-09-30 | −$165,341 | $252,183 | — | −671.46% |
| Q2 2022 | 2022-06-30 | −$284,825 | $238,925 | — | −1001.81% |
| Q1 2022 | 2022-03-31 | −$316,227 | $288,056 | — | −2298.33% |
| Q4 2021 | 2021-12-31 | −$237,955 | — | — | −915.67% |
| Q3 2021 | 2021-09-30 | −$417,524 | — | — | −2167.15% |
| Q2 2021 | 2021-06-30 | −$523,750 | — | — | −1719.52% |
| Q1 2021 | 2021-03-31 | −$604,283 | — | — | −2743.87% |
| Q4 2015 | 2015-12-31 | −$190,382 | — | — | −483.55% |
| Q3 2015 | 2015-09-30 | −$208,437 | — | — | −394.25% |
| Q2 2015 | 2015-06-30 | −$502,395 | — | — | −643.58% |
| Q1 2015 | 2015-03-31 | −$117,692 | — | — | −97.27% |
| Q1 2013 | 2013-03-31 | −$64,075 | $134,007 | — | −284.07% |
| Q4 2012 | 2012-12-31 | −$151,697 | — | — | −95.51% |
| Q3 2012 | 2012-09-30 | −$294,334 | $592,057 | — | −2226.26% |
| Q2 2012 | 2012-06-30 | −$77,129 | — | — | −473.16% |
| Q1 2012 | 2012-03-31 | −$198,082 | — | — | −1326.38% |
| Q3 2011 | 2011-09-30 | −$886,391 | −$503,500 | — | −351.98% |
| Q3 2010 | 2010-09-30 | −$382,891 | — | — | −106.38% |
Nutra Pharma free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$883,991 to −$1.2M, a net decrease of $306,025. Nutra Pharma's latest reported quarter, Q4 2025, generated −$219,818 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Nutra Pharma source filings ↗